Core Insights - MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing precision peptide therapies for endocrine and metabolic disorders [1][3] - The company will present at the 37th Annual Piper Sandler Healthcare Conference on December 2-4, 2025 [1][2] Company Overview - MBX Biosciences utilizes its proprietary PEP™ platform to discover and develop novel peptide therapies [3] - The company has a pipeline that includes canvuparatide (MBX 2109) for chronic hypoparathyroidism and imapextide (1416) for post-bariatric hypoglycemia, both in Phase 2 development [3] - An obesity portfolio is also in development, including MBX 4291 in Phase 1 and several pre-clinical candidates [3] - The company is based in Carmel, Indiana [3]

First-ever multi-year agreement highlights commitment to French electrophysiology marketFORT MILL, S.C., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announces its third VIVO™ system installation in France, at the prestigious Centre Hospitalier Régional Universitaire (CHRU) Nancy. Led by Prof. Christian de Chillou, a renowned expert in ...

VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology business solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, today announces the closing of its acquisition of Rampart Surveys Inc., a Woodland Park, Colo.-based land surveying firm with nearly three decades of experience. This transaction marks ZenaTech’s 12th acquisition, ...

Core Viewpoint - The Chefs' Warehouse, Inc. will participate in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference on December 2, 2025, at 8:45 a.m. ET [1]. Company Overview - The Chefs' Warehouse, Inc. is a leading distributor of specialty food products in the United States, the Middle East, and Canada, catering to chefs operating independent restaurants, fine dining establishments, and various culinary businesses [3]. - The company distributes over 88,000 products to more than 50,000 customer locations across its operational regions [3]. Investor Information - Investors and interested parties can access a webcast of the fireside chat through the company's investor relations website [2]. Contact Information - Investor relations contact is Jim Leddy, CFO, reachable at (718) 684-8415 [4].

Core Insights - Entera Bio Ltd. is a clinical stage company focused on developing oral peptide and protein replacement therapies for significant unmet medical needs, utilizing its proprietary N-Tab™ technology platform [3] Company Overview - Entera Bio is developing first-in-class oral peptide programs targeting PTH(1-34), GLP-1, and GLP-2, with its most advanced product candidate, EB613, aimed at treating post-menopausal women with low bone mineral density (BMD) and high-risk osteoporosis [3] - The company has successfully completed a placebo-controlled, dose-ranging Phase 2 study of EB613 tablets, which met both primary and secondary endpoints [3] - Other product candidates include EB612 for hypoparathyroidism and an oral oxyntomodulin for obesity and metabolic syndromes, as well as an oral GLP-2 peptide for rare malabsorption conditions in collaboration with OPKO Health [3] Upcoming Events - The CEO of Entera Bio, Miranda Toledano, will participate in a fireside chat at the 8th Annual Evercore ISI Healthcare Conference on December 3, 2024, in Coral Gables, Florida [2]

The Medidata Data Experience offering will enable the National Cancer Institute Lead Protocol Organizations to expedite the development of life-saving medicines for patientsNEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that Medidata Health Record Connect and Medidata Rave Companion, both integral components of the Medidata Data Experience, will be available to a select set of Nat ...

Transaction Creates a Public Vehicle for Scaling Captive Power Assets and Data Center Infrastructure, Targeting High-Growth data center and AI Markets CBDW to be acquired by Sim AgroCompany to purchase Power Assets for Data Centers Sim Agro has a proven record of power asset management New co to provide energy for AI infrastructure and Data Centers PHOENIX, Nov. 18, 2025 (GLOBE NEWSWIRE) -- 1606 Corp. (OTCID: CBDW) (“1606” or the “Company”) a leading AI company, is thrilled to announce that it has signed a ...

Boca Raton, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces two presentations at the upcoming 18th Clinical Trials on Alzheimer’s Disease conference (CTAD), in San Diego, CA on December 1-4, 2025. Presentations: Title:XPro1595, a Selective Soluble TNF Neutralizer, in Early Alzheimer’s Disease with Inflammation (ADi): Results from the Phase 2 MINDFuL Trial Date:Monday, December 1, until Tuesday December 2, 2025 Tim ...

First-to-market solution establishes a standardized workflow for scalable live event monetization; Roku among first to utilize Live SchedulerNEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ:MGNI), the largest independent sell-side advertising company, today introduced Live Scheduler, an industry-first offering. Live Scheduler helps media owners easily plan, activate, and measure ads around live events, from major sports matches to political debates, through a standardized framework that turns rea ...

Core Viewpoint - VVC Exploration Corporation has strategically restructured its mining projects in Mexico, focusing on cost discipline, safety, and risk management while reallocating resources to more promising projects [1][2][3] Project Review and Decisions - The exit from the Gloria Copper Project is aimed at reducing future cash outlays for maintenance and permitting amid political uncertainty in Chihuahua State [2][6] - Resources will be redirected to the Cumeral Gold Project, which has significant upside potential and local support for permitting and implementation [2][6] Cumeral Gold Project Details - The Cumeral Gold Project spans 1,665 hectares in northern Sonora, Mexico, and has shown promising geological indicators with historical assays reporting approximately 36% of samples assaying between 0.1–10 g/t Au [6] - Soil surveys have identified additional anomalies, and air-track drilling has revealed near-surface intervals of 0.21–0.44 g/t Au over lengths of 6–26 meters in key target areas [6] Company Overview - VVC Resources specializes in the exploration and development of natural resources, focusing on materials essential for high-tech industries and the green economy [3]